Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anthrax vaccines: Pasteur to the present.

A Scorpio1, T E Blank, W A Day

  • 1Bacteriology Division, United States Army Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Frederick, Maryland 21701, USA.

Cellular and Molecular Life Sciences : CMLS
|September 12, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathoadaptive mutations that enhance virulence: genetic organization of the cadA regions of Shigella spp.

Infection and immunity·2001
Same author

Novel topology of BfpE, a cytoplasmic membrane protein required for type IV fimbrial biogenesis in enteropathogenic Escherichia coli.

Journal of bacteriology·2001
Same author

N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates.

Journal of virology·2001
Same author

Cloning and characterization of a Campylobacter jejuni iron-uptake operon.

Current microbiology·2001
Same author

Shigella flexneri LuxS quorum-sensing system modulates virB expression but is not essential for virulence.

Infection and immunity·2000
Same author

Molecular variation among type IV pilin (bfpA) genes from diverse enteropathogenic Escherichia coli strains.

Infection and immunity·2000

Anthrax vaccines have evolved significantly since the 1800s, improving safety and efficacy. Ongoing research into Bacillus anthracis aims to discover novel vaccine targets against resistant strains.

Area of Science:

  • Veterinary Medicine
  • Microbiology
  • Immunology

Background:

  • Anthrax has historically caused significant mortality in livestock and humans.
  • Extensive international efforts in anthrax vaccine development began in the late 19th century.

Observation:

  • Vaccination has dramatically reduced anthrax infection rates in animals.
  • Anthrax vaccines have progressed from whole-cell preparations to advanced recombinant antigens.

Findings:

  • Vaccine refinements have enhanced safety without compromising efficacy.
  • Genomic and proteomic approaches are identifying new targets for anthrax vaccines.

Implications:

  • Future anthrax vaccines may utilize recombinant protective antigen for improved safety and efficacy.

Related Experiment Videos

  • Research is crucial to counter the threat of antibiotic and vaccine-resistant Bacillus anthracis strains.